Potential signatures determining tumor immunogenicity were compared between the two clusters: TMB (Figure 5A), neoantigen load (Figure 5B), HRD (Figure 5C), CTA score (Figure 5D), ITH (Figure 5E), and MHC-related antigen-presenting capability (Figure 5G). Here, HLA-C is linked to neoplasm.